Compare CDLX & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDLX | KRMD |
|---|---|---|
| Founded | 2008 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.0M | 192.5M |
| IPO Year | 2018 | 2019 |
| Metric | CDLX | KRMD |
|---|---|---|
| Price | $3.88 | $3.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $2.25 | ★ $6.50 |
| AVG Volume (30 Days) | 32.9K | ★ 168.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 50.13 | ★ 53.85 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $233,273,000.00 | $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | $8.82 | $17.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $0.55 | $3.09 |
| 52 Week High | $6.40 | $6.61 |
| Indicator | CDLX | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.18 | 39.58 |
| Support Level | $3.51 | $3.18 |
| Resistance Level | $4.52 | $3.43 |
| Average True Range (ATR) | 0.24 | 0.11 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 41.76 | 42.93 |
Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.